Medibact GuidesShop at Medibact

Stacking Module

NAD+ Stacking Module

Injectable NAD+ is the most-marketed compound in the longevity group and the one whose stacking discussion is most disconnected from its pharmacology. Its combinations are all thematic — grouped by the idea of cellular energy rather than by specified interacting mechanisms.

NAD+ Guide at MedibactNAD+ calculatorPeptide Stacking Guide

Educational use only — not medical advice. This page summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.

How to think about stacking NAD+

  • NAD+ is a coenzyme central to cellular energy metabolism, not a receptor-binding peptide. It is supplied rather than signalled, which makes 'mechanism collision' reasoning largely inapplicable.
  • Reported administration is uncomfortable at speed — flushing, chest tightness and nausea are commonly reported with rapid delivery, which is why slow administration is emphasised.
  • Amounts reported are large relative to peptides, so its figures do not transfer to or from them.
  • No controlled trial has studied injectable NAD+ combined with anything, and the evidence base for the injected form specifically is thin.

Combinations in detail

Mitochondrial energy pairing

NAD+ + MOTS-c
Why it is proposed
Coenzyme supply alongside AMPK signaling — supplying a substrate and activating a pathway are different things, which is the clearest version of this stack's rationale.
What is reported in practice
Separate administration; NAD+ reported slowly.
Cautions specific to this combination
No combination data. NAD+'s injected-form evidence is the weaker half.

Mitochondrial protection stack

NAD+ + SS-31
Why it is proposed
Substrate supply alongside cardiolipin-targeted membrane support.
What is reported in practice
Separate administration.
Cautions specific to this combination
SS-31's clinical record is mixed; combining two mitochondrial approaches does not resolve that.

Cellular-repair longevity stack

NAD+ + Epithalon
Why it is proposed
Thematic longevity pairing rather than a specified mechanistic interaction.
What is reported in practice
Reported in courses following Epithalon's short-course convention.
Cautions specific to this combination
Epithalon's literature is concentrated in one research tradition with no controlled human telomere data. The pairing is thematic.

Systemic recovery pairing

NAD+ + BPC-157
Why it is proposed
Energy-metabolism support alongside tissue-repair signaling; unrelated mechanisms.
What is reported in practice
Separate vials and schedules.
Cautions specific to this combination
No combination data.

What to avoid, and why

  • Rapid administration — reported tolerability problems are dose-rate dependent and are the most consistently reported issue with this compound.
  • Carrying NAD+ amounts across to peptide arithmetic; the scales are entirely different.
  • Reading NAD+ precursor supplement research as evidence for the injected form.

Related reading

The Peptide Stacking GuideAll stacking pages

Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.